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Abstract
Background: To broaden the range of outcomes that we can measure for patients undergoing
treatment for oncological and other chronic conditions, we aimed to validate a questionnaire
measuring self-reported autonomic regulation (aR), i.e. to characterise a subject's autonomic
functioning by questions on sleeping and waking, vertigo, morningness-eveningness,
thermoregulation, perspiration, bowel movements and digestion.
Methods: We administered the questionnaire to 440 participants (&#x2640;: N = 316, &#x2642;:
N = 124): 95 patients with breast cancer, 49 with colorectal cancer, 60 with diabetes mellitus, 39
with coronary heart disease, 28 with rheumatological conditions, 32 with Hashimoto's disease, 22
with multiple morbidities and 115 healthy people. We administered the questionnaire a second
time to 50.2% of the participants. External convergence criteria included the German version of
the Hospital Anxiety and Depression Scale (HADS-D), a short questionnaire on morningness-
eveningness, the Herdecke Quality of Life Questionnaire (HLQ) and a short version questionnaire
on self-regulation.
Results: A principal component analysis yielded a three dimensional 18-item inventory of aR. The
subscales orthostatic-circulatory, rest/activity and digestive regulation had internal consistency
(Cronbach-α: rα = 0.65 – 0.75) and test-retest reliability (rrt = 0.70 – 85). AR was negatively
associated with anxiety, depression, and dysmenorrhoea but positively correlated to HLQ, self-
regulation and in part to morningness (except digestive aR) (0.49 – 0.13, all p < 0.05).
Conclusion: An internal validation of the long-version scale of aR yielded consistent relationships
with health versus illness, quality of life and personality. Further studies are required to clarify the
issues of external validity, clinical and physiological relevance.
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The importance of quality of life research in relation to
health care evaluation is now well established. General
inventories of health-related quality of life (HRQL) have
established that patients with psychosomatic symptoms
can have greater impairments of HRQL and daily func-
tioning, than severely ill patients suffering from chronic
physical conditions [1,2]. Smith and colleagues' meta-
analysis of 12 studies [3] measuring the relationship of
physical, mental and social factors and global quality of
life found that HRQL was more strongly associated with
mental than with physical health status. Therefore general
HRQL scales potentially underestimate physical func-
tional loss in chronically ill people [3]. Disease specific
HRQL-questionnaires are more sensitive instruments for
specific condition, but outcomes cannot be compared
across conditions. We aimed to develop a questionnaire
that measures physical symptoms related to autonomic
function across a range of chronic conditions and that was
sensitive enough to capture both somatic functions and
somatic functional loss [4]. Physiologically measured cir-
cadian rhythm markers have been shown to be relevant
for recording health [5] and illness [6]. In the case of
hypertension in diabetic patients, nocturnal non-dipping
correlated with increased mortality rates [7]. Reduced
heart rate variability (HRV) is a risk factor for increased
mortality in various chronic conditions illnesses includ-
ing diabetes and coronary heart disease [8]. A loss of noc-
turnal cardio-respiratory coordination was seen in
patients with diabetes mellitus (types 1 and 2) and with
breast cancer, where the grade of loss was dependent on
the severity of the illness [9]. It was also shown that the
rest/activity rhythm was relevant in the prognosis for
metastasised colorectal cancer [10]. Affective and auto-
nomic disorders have been reported in manifest and
latent hypothyroidism [11].
To establish a systematic method of measuring chrono-
biological and autonomic function, we have developed an
inventory of self reported measures of autonomic regula-
tion. It includes questions pertaining to autonomic func-
tions such as rest/activity rhythms, vertigo, orthostatic
regulation, heat regulation, metabolism and digestion;
additional questions on activity aim to record self-
reported sleep duration and quality, as well as day-time
functioning which could reflect the rest/activity rhythm
[12]. We define autonomic regulation (aR) as the state of
regulation of different autonomic functions in the rhyth-
mic change of rest and activity. aR is influenced by consti-
tution, gender, age and disease and in healthy people, aR
is a relatively stable trait. Acute illness and chronic condi-
tions can lead to reduced aR, this is called loss of regula-
tion [13]. The potential relevance of these autonomic
functions as determinants of health and illness was first
articulated by Rudolf Steiner in the 1920s [14]. He formu-
lated questions about autonomic functions reflecting his
concept of strong or weak regulation of physical and func-
tional systems through spiritual strength, the so-called
ego-organization [14].
The relation between aR and health and personality mark-
ers can also be demonstrated, which supported Steiner's
idea that a strong regulation has an impact on health and
on personality markers [14,15]. High aR reflects an equil-
ibrated functioning of autonomic nervous system and
with low aR indicating the converse situation [12]. In a
cross-sectional study conducted from 2000 to 2001 with
the short version questionnaire, we have shown that peo-
ple with a range of chronic physical condition have a poor
aR [13].
The variation between individuals in autonomic tone
(from predominant vagotonia to sympathicotonia) is one
of the most elaborated and physiologically applicable
modern approaches to constitution [16]. Psychometri-
cally measured autonomic regulation shows clear concep-
tual convergence to and correlation with physiological
measurements of autonomic tone [17]. Moreover, consti-
tution is an important component in some complemen-
tary medicine treatment models. In the context of
anthroposophical medicine or homeopathy, constitution
is central to diagnostic and treatment decisions
[15,18,19]. For example calcium carbonicum can be used
in the treatment of night-sweats but it also represents a
constitutional type [19]. Yet we do not know if the remedy
reduces night-sweats more effectively in patients with the
calcium carbonicum constitution type. This type of empir-
ical question requires valid and reliable measures of auto-
nomic function.
Initial versions of the questionnaires testing autonomic
regulation did not perform well psychometrically [18,20].
We then developed a 12 item autonomic regulation (aR)
short version which had satisfactory reliability and valid-
ity [12] This version was then tested in a new sample of
408 patients with a range of medical conditions. [13] We
now report the further development and re-validation of
a longer (18-item) version of the aR scale which includes
questions of digestive regulation with the responses of the
same 408 patients in the previous analysis and an addi-
tional 32 patients with treated hypothyroidism. We aimed
to validate the German version of this longer aR question-
naire and test it further with a principal component anal-
ysis.
Methods
This multi-centre, cross-sectional study was carried out
from April 2000 – November 2001. The study centres,
sited in Germany, were the Havelhöhe Community Hos-
pital (Berlin), the Öschelbronn Oncological Practice andPage 2 of 13
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the study consisted of healthy volunteers and seven
groups of patients. The latter were recruited consecutively
among inpatients (Havelhöhe) and among outpatient
consultations in the other two study centres. The condi-
tions were: (1) histologically proven breast cancer and (2)
colorectal cancer; (3) diabetes mellitus (types 1 and 2);
(4) angiographically confirmed coronary artery disease
(CAD); (5) clinically and immunologically confirmed
rheumatological conditions (12 connective tissue disease,
11 rheumatoid arthritis, three spondylarthrosis, one pol-
yarteritis nodosa, one polymyalgia rheumatica); (6) sono-
graphically and immunologically confirmed (positive
TPO-Ak) Hashimoto's Disease (26 (substituted) with
euthyreosis and 6 with subclinical hypothyreosis) (table
1); and (7) patients with multiple conditions either with
two of the study conditions (1 to 6) or one of the chronic
study conditions with an additional cancer. We included
these conditions to test construct validity based on
hypotheses concerning aR for each condition: lowest aR
was hypothesised for patients with multiple conditions,
reduced aR was hypothesised in breast cancer, diabetes,
and the two auto-immune diseases and no reduction in
aR was hypothesised for CAD and colorectal cancer. For a
detailed socio-demographic description of the sample see
table 1. If a patient with an initial diagnosis of diabetes
mellitus had a coronary event or new diagnosis of CAD,
they were still analysed in the diabetes group. For all other
cases of new co-morbidity, the patients were analysed in
the multiple conditions group. The control group was
recruited from the Havelhöhe Hospital staff and their rel-
atives. 131 persons have been asked consecutively, 11
refused participation, after excluding relevant diseases the
questionnaire was filled out by 115 persons. Exclusion cri-
teria were: other severe organic conditions (with the
exception of the multiple conditions group), manifest
psychosis (because of potential insufficient compliance),
severe immobilisation or a Karnofsky index <50%, uncon-
trolled pain, recent operations (<1 week prior to study
recruitment) or recent chemotherapy or radiotherapy (<3
weeks prior to recruitment) to avoid the potential con-
founding of adverse effects of treatment and for a more
robust test-retest analysis. All participants gave their writ-
ten informed consent. We were not required to seek for-
mal ethics approval for this study by our institution,
although it fulfilled contemporary ethical standards for
psychometric studies.
The study we report here includes recapitulation of the
development process in order to integrate questions about
gastrointestinal function. We included 32 questions at the
start of the process including the 12 in the shorter aR ver-
sion [12] and 20 articulated (table 2) by a panel of seven
experts: 5 doctors (a gastroenterologist, two internists, a
Table 1: Sociodemographic data of the study groups including participation refusion and exclusion rate
TG CG BC CRC DM (1/2) CHD RD HD MC
Invited (n) 475 131 95 51 66 45 29 36 22
Consented (n) 452 120 95 51 60 42 28 34 22
Complete Data (n/%) 440/100 115/26.1 95/21.6 49/11.1 60/13.6 (20/40) 39/8.9 28/6.4 32/7.3 22/5.0
Women (n/%) 316/71.8 80/25.3 95/30.1 30/9.5 29/9.2 (10/19) 13/4.1 22/7.0 32/10.1 15/4.7
Men (n/%) 124/28.2 35/2.8 0/0 19/15.3 31/25.0 (10/21) 26/21.0 6/4.8 0/0 7/5.6
Age (mean) 56.8 54.0 57.1 62.0 53.7 67.3 47.7 52.1 65.1
(SD) (13.6) (14.2) (9.9) (12.2) (14.5) (9.3) (16.4) (12.6) (9.7)
Retest (n/%) 227/51.6 59/26.0 34/15.0 26/11.4 41/18.1 22/9.7 19/8.4 17/7.5 12/5.3
Test-Retest time in weeks Mean (SD) 13.1 (7.8)
Median (25/75% Quartils) 12.0 (6.0/19)
Marital Status
Married (n/%) 274/62.3 75/27.4 59/21.5 33/12.0 38/13.8 29/10.6 10/3.6 15/5.5 15/5.5
Single (n/%) 52/11.8 13/25.0 8/15.3 6/11.5 6/11.5 4/7.7 9/17.3 5/9.6 1/1.9
Divorced (n/%) 55/12.5 15/27.3 13/23.6 5/9.1 9/16.4 3/5.5 4/7.3 5/9.1 1/1.8
Widowed (n/%) 41/9.3 8/19.5 9/17.6 4/9.8 7/17.1 3/7.3 3/7.3 3/7.3 4/9.8
No details available (n/%) 18/4.1 4/22.2 6/33.3 1/5.6 0/0 0/0 2/11.1 4/22.2 1/56.
Most recent profession
Worker (n/%) 69/15.7 6/8.7 12/17.4 12/17.4 18/26.1 9/13.0 5/7.2 3/4.3 4/5.8
Employee/civil servant (n/%) 245/55.7 72/29.4 45/18.4 22/8.9 35/14.3 25/14.2 13/5.3 19/7.7 14/5
Self employed (n/%) 48/10.9 19/39.6 8/16.7 5/10.4 3/6.2 2/4.2 6/12.5 3/6.2 2/4.2
House wife/husband (n/%) 57/12.9 12/21.1 23/40.4 10/17.5 1/1.8 3/5.3 2/3.5 4/7.0 2/3.5
Still in education (n/%) 7/1.6 3/4.3 0/0 0/0 2/28.6 0/0 2/28.6 0/0 0/0
No details available (n/%) 14/3.2 3/21.4 7/50.0 0/0 1/7.1 0/0 0/0 3/21.4 0/0
Abbreviation: Total group (TG), Control (CG), breast cancer (BC), colorectal cancer (CRC), diabetes mellitus type 1/2 (DM), coronary heart 
disease (CHD), rheumatic diseases (RD), Hashimoto disease (HD), multiple conditions (MC)Page 3 of 13
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Table 2: Diagram of the 32 items of the analysis process with symbols (I-IV) indicating the point of exclusion
Non-validated items on autonomic regulation Responses
At what age did you need your first pair of glasses?I
If you tend towards vertigo, how long do your vertigo 
attacks usually last?I
seconds minutes hours
Do you take laxatives?II frequently occasionally never
At what time of day do you usually have bowel 
movements?II
morning midday evening
You need your glasses – if at all – to see things in focus... 
(this question does not distinguish between farsightedness 
in old age and youth).III
nearby no glasses necessary in the distance
What type of flavours do you prefer at breakfast?III sweet indifferent salty
Until 35 years of age you needed glasses to improve your 
vision because you were...III
short-sighted no glasses necessary far-sighted
Do you drink sweetened tea or coffee?III rarely occasionally frequently
When taking a walk, do you usually notice anything of 
interest ...III
close by (i.e. on indifferent far away the 
ground etc.) (horizon etc.)
Do you usually have bowel movements after meals?III rarely occasionally frequently
Do you remember dreaming?IV frequently occasionally rarely
Did you experience dental problems early in your youthIV frequently occasionally rarely
Do you consider yourself to be skilful and dexterous?IV rarely occasionally frequently
Can you cope with eating big meals?IV hardly reasonably well very well
Validated items Possible answers On autonomic regulation
Low = 1 average = 2 high = 3
Do you suffer from dizzy spells? frequently occasionally never
Do you suffer from dizziness when you look down from a 
height?
frequently occasionally never
Do you suffer from dizziness when you get up in the 
morning?
frequently occasionally never
Do you suffer from dizziness when you straighten up or 
bend down?
frequently occasionally never
Do you tend to have cold or cold-sweaty hands even in the 
warmer months?
frequently occasionally rarely
Do you suffer from travel sickness (e.g. sea sickness)? frequently occasionally almost/never




Do you have to pull yourself together to go to work? frequently occasionally rarely
Do you feel rested in the morning rarely occasionally frequently
Do you have problems falling asleep? frequently occasionally rarely
Do you tend to sweat? frequently occasionally rarely
Do you suffer from disturbed sleep? frequently occasionally rarely
At what time of the day do you feel most comfortably? evening in the middle of the day morning
Do you tend to sweat at night? frequently occasionally rarely
Do you tend to have stomach growling? frequently occasionally rarely
Rest/activity regulation
How often do you have bowel movements? <1/day approx. 1/day >1/day
Do you normally have bowel movements at regular times? rarely occasionally frequently
Do you suffer from constipation? frequently occasionally rarely
Digestive regulation
18 item sumscale
(I plausibility items, II answer boxes below 5% or more than 75%, III insufficient item-total/Cronbach-α, IV insufficient factor loading). 18 validated 
items on autonomic regulation, including the individual, possible answers, item and scale correlation with the convergence criteria aR-short version. 
The first twelve items are also concerning to the short version scale on aR. The left answer corresponds to low (1 point), the middle to average (2 
points) and the right to high autonomic regulation (3 points).
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oncology), a statistician and a psychometrician. We then
performed reliability and factor analyses. (table 2).
Convergence criteria
1) Marburg short questionnaire on chronotypology
(MQC) (table 3 I) consists of 5 items relating to morning-
ness/eveningness and is an extraction of the Horne-
Ösberg Questionnaire [21] with a four or five Likert scale
and a range of 4 – 24. High rating means morningness
and low rating points out eveningness. It's reliability and
validity are adequate: Cronbach-alpha = 0.73, test-retest
reliability = 0.78) [22,23] and it is a pragmatic, short
measure for characterising an individual's chronotypol-
ogy.
2) The German version of the Hospital Anxiety and
Depression Scale (HADS-D) consists of 14 items (7 for
anxiety and 7 for depression) on which people rate on a
four-point Likert scale (0–21 both). Higher scoring indi-
cate more symptoms, ≥ 11 points anxiety or depression
are probable, ≥ 8 – 10 possible cases, <7 no cases. The
HADS is highly reliable and valid and is an extensively
used scale in family medicine and internal medicine
research and audit [24,25].
3) The Grossarth-Maticek short questionnaire on self-reg-
ulation is a scale with 16 items for measuring self-regula-
tion and health-building activity with a six-point-Likert
scale. The 16 items are summed and divided by 16 to
obtain a total score. A higher score indicates better self-
regulation. The validity and reliability of the question-
naire are good: Cronbach-alpha = 0.80 and test-retest reli-
ability = 0.82). We used this scale because of it's
conceptual congruence with aspects of autonomic regula-
tion. [26].
4) The Herdecke Quality of Life Questionnaire (HLQ) is a
HRQL questionnaire with 35 items in 6 subscales (physi-
cal problems, digestive wellbeing, motility, mental bal-
ance, social interaction) showing good validity and
reliability in large German samples. Answers are struc-
tured in a five-point-Likert scale which are transformed to
percent values between 0 and 100% (best possible HRQL)
[27]. We administered it as one would expect convergence
between aR and HQRL. Questions on autonomic state,
heat sensitivity, general constitution, current and past ill-
nesses, medication were collected by questionnaire (table
3 II) and semi-standardised interviews [12].
Table 3: Marburg short questionnaire on chronotypology and items on the autonomic nervous system
(I) Marburg short questionnaire on chronotypology Possible answers
At what time would you like to get up in the morning? before 6.20 hrs, 6.20 hrs – 7.45 hrs, 7.45 hrs – 9.50 hrs, 9.50 hrs – 10.50 hrs, after 
10.50 hrs
How difficult is it for you to get up in the morning? not difficult rarely difficult not easy very difficult
In the last 14 days, how often did you go to bed late without 
reason and ended up feeling that you hadn't really slept long 
enough?
never once 2–3 times frequently
At what time in the evening do you usually feel tired and find 
it necessary to go to bed?
before 20.50 hrs, 20.50 hrs – 22.10 hrs, 22.10 hrs – 0.50 hrs, 0.50 hrs – 2.00 hrs, 
after 2.00 hrs
You will have heard of the so called "morning people", who 
feel at their best in the morning and „evening people", who 
feel at their best in the evening- which of these groups would 
you consider yourself to belong to?
definitely a morning person, more a morning than an evening person, more an 
evening person than a morning person, definitely an evening person
(II) Questions on autonomic function, heat sensitivity, 
general constitution, illnesses and symptoms
Possible answers
Do you tend to sweat through your head and extremities 
even in the colder months?
frequently occasionally rarely
Do you tend to feel cold and to shiver? frequently occasionally rarely
In the last few years, have you reacted to common colds with 
a temperature over 38°?
frequently occasionally rarely
Do you generally tend to feel quite low? frequently occasionally rarely
Do you have any allergies? yes no
Which childhood illnesses did you have? measles, scarlet fever, whooping cough, rubella, mumps, chicken-pox
How many days was your average menstrual cycle? a) 
between the ages of 21–30 : b) at present:
over 28 days ca. 28 days under 28 days
How strong are/were your period pains? a) between the ages 
of 21–30: b) at present:
little pain average pain strong pain with hours spent in bed
BMI age 21–30 BMI age 40–45 BMI today Kg/m2Page 5 of 13
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Our criterion for acceptability of a questionnaire item was
that 95% or more of participants had to complete it. Items
were also dropped if less than 5% or more than 75% of
participants scored one. Finally, all items with item-total-
correlations less than 0.10 and greater than 0.70 were
excluded.
Principal component analysis
A principal component analysis (rotation: varimax with
Kaiser normalisation) was conducted with data from all
participants on the acceptable items, with an optimality
assessment of the two-, three-, four- and five-factor model,
respectively, at a minimum factor load of r = 0.35. Only
items that loaded on a factor remained in the scale.
Internal consistency, reliability and convergence validity 
analyses
For both the total score and the resulting subscales, inter-
nal consistency was assessed with the Cronbach-α coeffi-
cient [28]; test-retest-reliability and pair-wise correlations
between the subscales were assessed with Spearman rank
correlations. We measured convergence validity (instru-
ments measuring aspects hypothetically influencing aR)
with Spearman rank correlations [29].
Discriminant validity
We based analysis of discriminant validity on differences
between each of the chronic condition groups and the
healthy group with gender as a fixed factor and age as a
continuous covariate, estimating each parameter's influ-
ence on the total aR-score and each of its subscales. We
adjusted the p-values and confidence intervals of the
seven resulting pair-wise comparisons, controlling for the
aR-score, for multiple-testing with the Dunnett adjust-
ment in order to keep the aR-scale-wise alpha error on a
global level of 5%.
All analyses were performed with SPSS 13.0 and SAS 9.1.3
statistical packages.
Results
We invited 475 people to participate in our study; 452
consented (95%) and we had complete data on 440 par-
ticipants (93%). Participants consisted of a healthy con-
trol group (n = 115) and seven patient groups (n = 325)
(table 1). The average age of participants was 56.8 years
(SD = 13.6), with ages ranging from 18–85 years. 227 par-
ticipants (51.6%) were re-tested when they re-attended an
outpatients clinic or were re-admitted two weeks to six
months after the initial questionnaire administration
(table 1). The second test was carried out after a median of
12.0 weeks (table 1).
Item acceptance and selection
The item acceptance was ≥ 95% for all items with the
exception of "length of vertigo attack" (27.4%). From the
initial 32 items (table 2) two items (having glasses and
length of vertigo attack) were used as plausibility items
and not as items for reliability analysis (table 2: I), two
items in the completed answer boxes were below 5% and
were consequently excluded (table 2: II): "laxative taken"
(frequency = 3.1%) and "when do you have bowel move-
ment?" (evening = 4.4%). Due to insufficient item-total
correlation and because of an improved Cronbach-α
when the item was excluded six items (table 2: III) were
dropped from the questionnaire. In this first step 22 items
were pre-selected.
Principal component analysis
On the basis of these 22 items, we performed a principal
component analysis. A four-principal-component model
(seven, four, three and three items, respectively) fulfilled
the Kaiser criterion [30] and showed an unambiguous
model of an orthostatic-circulatory, digestive and a split
component of sleep and daily regulation. The most con-
vincing model was the one with three unambiguous com-
ponents (table 4) as this model represented the most
combination of items with highest face validity, and
because only the eigenvalues of these three factors were
larger than those of equivalent null models (with only
random associations) which were generated for compari-
son by a Monte-Carlo simulation. The last four eliminated
items see table 2: IV. Therefore, we chose an 18-item total
score with three subscales as the most appropriate repre-
sentation of the data Factor 1 (orthostatic-circulatory reg-
ulation) explains 10.2%, factor 2 (rest/activity regulation)
explains 8.2% and factor 3 (digestive regulation) explains
5.9% of total variance.
Reliability
All 18 items were checked for total score, seven items for
the subscales orthostatic-circulatory, eight items for rest/
activity- and three items for digestive regulation: The
Cronbach-α coefficients varied between 0.75 – 0.65, item-
subscales correlation rtr = 0.57 – 0.17 and test-retest relia-
bility rrt = 0.85 – 0.70 (table 4)
Convergence validity
Low-level aR-scores in sum- and subscales correlated with
features of chronic conditions and mental health, with the
exception of the digestive regulation subscale: anxiety (A-
HADS), depression (D-HADS), low general feeling, aller-
gies and dysmenorrhoea, (r = 0.49 – 0.13, p = 0.001).
High-level aR-scores in sum- and subscales correlated
with the following quality of life dimensions and person-
ality traits: physical complaint, digestive well-being,
motility, mental balance, social interaction and initiative
power in the HLQ as well as high self-regulation andPage 6 of 13
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between the digestive aR-scale and MQC (r = 0.41 – 0.13,
all other p < 0.05). High aR-scores were associated with
thermoregulation, with the exception of the digestive reg-
ulation subscale: less perspiration and less feelings of cold
(r = 0.33 – 0.15) (both p < 0.05). (all convergence corre-
lations see in table 5)
Discriminant validity
Participants in the healthy control group consistently had
the highest aR-score; participants with breast cancer, dia-
betes (both in sum- and subscale 2), rheumatological con-
ditions (sum- and subscale 1) and Hashimoto disease
(subscale 3) had a reduced aR-score and the multiple con-
ditions group the lowest aR-score in all scales. Men
showed a higher aR-score than women (table 6, 7). Over-
all 92.2% of participants with chronic conditions show a
loss of autonomic regulation and 30.2% of the healthy
group, which may be a constitutional problem.
Discussion
We developed a reliable and valid instrument for charac-
terising autonomic regulation with 18 items [29]. As the
questions on the various autonomic functions are heter-
ogenous, we conducted a factor analysis and detected the
underlying subscales with satisfactory internal consist-
ency: sleep rhythm and daily functioning (rest/activity),
orthostatic-circulatory and digestive regulation. In this re-
analysis we integrated in the scale items with a clear rela-
tionship to the autonomic nervous system and that
showed a clear loading pattern. Items such as dental
health, dreaming, being skilful, and flavour preference did
not load. To highlight the relationship of the items to
underlying physiological function, we changed the name
Table 4: List of the 18 items on autonomic regulation with the relevant factor loading (r>0.35 in bold and minor co-loading in standard 
letters), α-if item deleted, item-subscale correlation, internal consistency (Cronbachs-α) and test-retest reliability, mean of items and 
subscales with standard deviation (SD)







dizzy spells 0.708 0.225 -0.034 0.661 0.564 2.49 (0.60)
dizziness when looking 
down
0.593 0.117 0.075 0.684 0.451 2.18 (0.78)
dizziness when getting up 
in the morning
0.634 0.336 -0.058 0.670 0.520 2.50 (0.62)
dizziness when straighten 
up or bend down?
0.675 0.274 -0.083 0.662 0.553 2.25 (0.63)
cold or cold-sweaty 
hands
0.409 0.075 0.075 0.735 0.248 2.48 (0.75)
travel sickness 0.505 -0.143 0.023 0.716 0.316 2.51 (0.69)
dizzy from circular 
motions
0.607 0.063 0.091 0.687 0.443 1.88 (0.81)
Orthostatic-
circulatory regulation
rα = 0.733/rrt = 0.819 16.28 (3.05)
pulling together to go to 
work
0.108 0.601 -0.097 0.614 0.390 2.39 (0.64)
rested in the morning -0.005 0.700 -0.001 0.598 0.440 2.39 (0.74)
problems falling asleep 0.105 0.548 0.244 0.606 0.408 2.36 (0.77)
tend to sweat 0.130 0.416 0.037 0.630 0.315 2.14 (0.77)
suffering from disturbed 
sleep
0.119 0.636 0.132 0.588 0.472 2.18 (0.77)
time of the day feeling 
most comfortably
-0.072 0.351 -0.090 0.677 0.166 2.07 (0.89)
sweat at night 0.175 0.447 0.112 0.619 0.359 2.47 (0.72)
stomach growling 0.198 0.405 -0.080 0.643 0.261 2.30 (0.70)
Rest/activity 
regulation
rα = 0.661/rrt = 0.767 18.25 (3.34)
bowel movements 
frequency
0.016 0.005 0.765 0.535 0.453 2.07 (0.58)
bowel movements 
regularly
0.001 0.011 0.713 0.608 0.409 2.49 (0.72)
constipation 0.223 0.175 0.756 0.480 0.490 2.67 (0.60)
Digestive regulation rα = 0.645/rrt = 0.704 7.24 (1.46)
Total aR-scale rα = 0.751/rrt = 0.851 41.79 (5.80)
(coefficients with p < 0.05 are presented in bold letters, p > 0.05 in standard letters)Page 7 of 13
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tion.
All items show an unambiguous factor loading pattern in
the whole sample (table 4) and in patients with chronic
conditions. In the healthy group the factor model is more
ambiguous. This could be related to the smaller number
of symptoms in people without chronic conditions and
the potential greater effect of factors operating as traits.
The digestive regulation subscale has low correlation with
the other both subscales, which reflects the relative heter-
ogeneity of the different autonomic functions that are
integrated in the whole inventory. This does not invali-
date the total score and potentially increases the utility of
the subscales in different clinical conditions. Most HRQL
scales report the global scores and the scores for sub-
scales.
Overall, we can conclude that the long version aR scale
not only has increased content and face validity but
improved reliability (table 4). The test-retest reliability is
satisfactory to good, in spite of the heterogeneity and long
test-retest interval (13.1 weeks). The test-retest reliability
is consistent with the concept of character traits, although
this would need to be confirmed with a repeated measures
analysis over a longer period of time. Discriminant valid-
ity show significant differences (3.2 to 6.5 in total- and
subscales) between healthy people and those with chronic
conditions. These absolute differences correspond to 9 –
18% relative differences, which is likely to be meaningful
clinically [31]. The utility of a scale cannot be based on its
psychometric properties alone. We agree with Hyland that
although a "scale should satisfy certain minimum criteria
(satisfying Cronbach-α and test-retest-reliability and vali-
dating criteria), they do not form an essential part of
choosing between scales. The best way to select...is exam-
ine the items of the scale carefully, and judge to what
extent the set of items...matches the requirements of the
research" [32]. Below we discuss the sub-scales of the
questionnaire.
1) Orthostatic-circulatory regulation
Previous research has shown that "dizziness on rising",
"dizziness on bending over" and "dizziness on looking
down," (classed as orthostatic vertigo) are correlated [12]
to "dizzy from circular motions" and to low levels of aR
[12] in patients with physical illnesses. We confirmed this
interaction in this analysis and can also apply this range
of symptoms to travel sickness and "dizzy from circular
motions" (table 4). Orthostatic intolerance has been
observed in young women with high sympathetic drive
and relative instability of their autonomic nervous system
[33], but also in people with diabetes mellitus, breast can-
cer and coronary artery disease [34], auto-immune disor-
ders (including rheumatological conditions) and chronic
fatigue syndrome [35]. The correlation between "cold
extremities" (stimulated α-adrenoreceptors) with high
sympathetic drive [12,36] and questions on vertigo and
dizziness are weak and could be regarded as signs of
malaise or loss of regulation in illness. People with multi-
ple and rheumatological conditions have the lowest score
on this subscale. Tolerance of cold is moderately associ-
ated with and less perspiration is weakly associated with
high-level orthostatic-circulatory regulation, which could
Table 5: List of Spearman correlations between the aR sum- and subscales and the convergence criteria
AR- sumscale orthostatic-circulatory regulation rest/activity regulation digestive regulation
AR -sumscale
orthostatic- circulatory regulation 0.781
rest/activity regulation 0.810 0.373
digestive regulation 0.375 0.150 0.120
A-HADS 0.495 0.341 0.486 0.133
D-HADS 0.349 0.212 0.368 0.127
Self- regulation 0.346 0.236 0.332 0.142
MQC 0.306 0.132 0.403 0.020
HLQ-Physical Complaint 0.399 0.244 0.368 0.204
HLQ-Digestive Wellbeing 0.356 0.267 0.315 0.191
HLQ-Motility 0.400 0.250 0.379 0.187
HLQ-Mental Balance 0.518 0.316 0.527 0.180
HLQ-Social Interaction 0.391 0.279 0.383 0.146
HLQ-Initiative Power 0.373 0.227 0.366 0.192
General feeling 0.358 0.239 0.367 0.140
Less Allergies 0.184 0.159 0.151 -0.012
Less Dysmenorrhoea 0.325 0.280 0.262 0.195
Less Perspiration 0.277 0.156 0.330 0.010
Less Feeling Cold 0.247 0.307 0.153 0.013
(coefficients with p < 0.05 are presented in bold letters, p > 0.05 in standard letters)Page 8 of 13
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between perspiration and vasoconstriction. These func-
tions are dependent on circadian rhythm and also on vig-
ilance, personality and gender [37].
2) Rest/activity regulation
The variables "difficulties falling asleep", "disturbed
sleep", "having had a good sleep" and "having to pull
oneself together to do something" had a wide range of
inter-item-correlation (r = 0.16 to 0.56) and item-total-
correlation, consistent with variation found in other stud-
ies of psychometric measures and sleep monitoring
[38,39]. The interaction between physical activity, ability,
"having to pull oneself together" and sleep quality
("being rested") and its relationship to circadian well-
being ("morningness") has also been reported by other
investigators [40,41] as has its relationship with perspira-
tion [12,36]. The physiological mechanism of the interac-
tion of "stomach growling" to rest/activity is unclear, but
a raised low frequency (LF) power when awake and low-
ered high frequency (HF) power during non-REM-sleep
have been observed and point towards complex auto-
nomic dysfunction in functional digestive disorders [42].
The reduced aR total score of the breast cancer group is
partly determined by reduced rest/activity regulation and
could therefore reflect the patients' cancer related fatigue
(CRF) which affects more than 70% of these patients dur-
ing chemotherapy and 34% of the patients up to ten years
after remission [43]. With different CRF inventories mod-
erate to high correlation with aR has been documented
and the association between poor rest/activity regulation
to CRF has face validity [44]. The reason why the aR scale
did not have discriminant validity for colorectal cancer
patients may be because the conventional chemotherapy
regimes for colorectal cancer in 2000–2001 (5-Fluoru-
racil/leucovorine) had fewer adverse effects than for breast
cancer, with a CRF-prevalence range from 5 to 20% [45].
In the diabetes group the reduced rest/activity regulation
could be related to sleep apnoea and restless legs syn-
dromes (RLS) which occur in about 36% and 27% respec-
tively in type 2 diabetes [46,47]; sleep disturbances are
also elevated in diabetes mellitus type 1 [48].
3) Digestive regulation
Our study is the first to integrate questions on gastrointes-
tinal symptoms into a measure of aR. Migrating motor-
complexes are determinants of gastrointestinal function-
ing. They are dependent on circadian rhythms, with a
postprandial pattern maximum at breakfast time [49]
with variation between individuals. [50]. This may
account for the unreliability of questions about bowel
movements at specific times of day. The association
between functional bowel disorders and reduced heart
rate variability [42] and the influence of light on gut elec-
trophysiological function [51] is a potential area for fur-
ther investigation of digestive disorders. Reduced
digestive regulation in the multiple conditions group is
related to the global loss of regulation in these patients.
The loss of digestive aR in those patients with Hashim-
oto's disease could be due to 6 patients with sub-clinical
(untreated) hypothyroidism.
Patients with cancer have high levels of anxiety and
depression and these may have an adverse effect on HRQL
and survival [52]. Depression and anxiety is also more
prevalent in people with diabetes mellitus [53,54] and
heart disease, and can worsen prognosis in the latter con-
dition [55,56]. Higher self regulation in patients with can-
cer or coronary heart disease is associated with improved
prognosis [26,55]. It is possible that improved autonomic
regulation is a potential mediator through its association
with reduced anxiety, depression and self-regulation.
The moderate correlation of aR to all HRQL dimensions
of the HLQ is consistent with a recent study by Mormont
& Waterhouse [56] who reported a correlation between a
disturbed circadian rhythm with fatigue during the day (r
= 0.37) and global HRQL (r = 0.34). We consider that the
strong correlation between aR and mental balance, physi-
cal complaints and gastrointestinal motility supports our
conceptualisation of aR and strengthens the case for meas-
uring it. The relationship between high level aR and
morningness seen in earlier studies was confirmed [12].
Otsuka has shown that an earlier acrophase of systolic and
diastolic blood pressure is accompanied by positive mood
and more balanced diet [57]. This in turn concurs with
our concept that morningness can be viewed as a marker
Table 6: Raw-data means and SD separated for gender and age classes with sum-scale and subscales.






Women 316 41.0/5.8 15.7/3.1 17.9/3.3 7.1/1.5
Men 124 43.8/5.2 17.4/2.9 18.7/3.4 7.3/1.4
lower third (18–40) 59 41.3/4.6 15.9/3.0 18.3/2.8 7.1/1.3
middle third (41–62) 230 41.5/6.1 16.1/3.1 17.8/3.5 7.3/1.4
upper third (63–85) 151 42.4/5.6 16.4/3.2 18.4/3.3 7.0/1.6Page 9 of 13
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(phase delay syndrome) is associated with breast cancer
[58] and shows higher prevalence in sleep and psychiatric
disorders such as seasonal affective disorder, depression
and alcoholic consumption [59-61].
High aR scores are correlated with cardio-respiratory coor-
dination [12] and a loss of aR has been shown in patients
with chronic medical conditions in the short-version
questionnaire [13].
A limitation of our study was that validation of the scale
was confined to other inventories of self-reported symp-
toms. Polysomnography and actimeter-based studies are
required to investigate the physiological correlates of the
aR-scale. Another limitation was our choice of a low
threshold of 0.10 in the reliability analysis, necessitated
by the heterogeneous construct of autonomic regulation,
before conducting a principal component analysis. A lim-
itation that is intrinsic to the current version of the aR
scale is the measuring of a combination of trait status. This
may explain why the scale has a high sensitivity (92%) for
detecting loss of regulation in patients with chronic con-
ditions but a low specificity, ascribing low aR to 30% of
healthy controls, probably detecting a constitutional
(trait) deficit. This hybrid nature of the scale, detecting
both aR trait and loss of regulation may also explain as
well why the 3 factors have a cumulative variance of only
Table 7: Test of discriminant validity between controls and patient groups and gender with estimation of the means of aR with a linear 
model with the discrete factors diagnosis and gender and the steady covariate age
Conditions of participants Estimation of the means of aR Total score 95%-Confidence interval p-value
No chronic condition 44.8 43.7 – 45.8
Breast cancer 41.6 40.3 – 42.9 0.0004
Colorectal cancer 42.5 40.8 – 44.1 0.1284
Diabetes mellitus 41.1 39.7 – 42.4 0.0002
Rheumatological condition 41.5 39.5 – 43.6 0.0304
Coronary heart disease 42.5 40.5 – 44.4 0.2645
Hashimoto disease 43.0 41.0 – 44.9 0.4827
Multiple conditions 38.3 36.0 – 40.5 <.0001
Gender: Women Men 40.5 43.4 39.7 – 41.2 42.3 – 44.4 <.0001
1) Orthostatic-circulatory aR
No chronic condition 17.4 16.8 – 18.0
Breast cancer 16.7 15.9 – 17.4 0.4443
Colorectal cancer 16.5 15.5 – 17.4 0.4036
Diabetes mellitus 16.4 15.6 – 17.1 0.1840
Rheumatological condition 15.7 14.6 – 16.8 0.0463
Coronary heart disease 16.3 15.3 – 17.4 0.4640
Hashimoto disease 17.3 16.2 – 18.4 1.0000
Multiple conditions 15.4 14.2 – 16.7 0.0306
Gender: Women Men 17.4 15.1 – 15.9 16.8 – 18.0 <.0001
2) Rest/activity aR
No chronic condition 19.8 19.1 – 20.4
Breast cancer 17.5 16.7 – 18.2 <.0001
Colorectal cancer 18.5 17.5 – 19.5 0.1695
Diabetes mellitus 17.6 16.8 – 18.4 0.0003
Rheumatological condition 18.4 17.2 – 19.6 0.2256
Coronary heart disease 18.7 17.5 – 19.9 0.5671
Hashimoto disease 18.9 17.8 – 20.1 0.7362
Multiple conditions 16.5 15.2 – 17.9 0.0001
Gender: Women Men 17.9 18.5 17.9 – 18.4 17.9 – 19.2 0.1406
3) Digestive aR
No chronic condition 7.6 7.3 – 7.9
Breast cancer 7.5 7.1 – 7.8 0.9917
Colorectal cancer 7.6 7.1 – 8.0 1.0000
Diabetes mellitus 7.1 6.7 – 7.5 0.2094
Rheumatological condition 7.5 6.9 – 8.0 0.9990
Coronary heart disease 7.4 6.9 – 8.0 0.9969
Hashimoto disease 6.8 6.2 – 7.3 0.0446
Multiple conditions 6.3 5.7 – 6.9 0.0020
Gender: Women Men 7.0 7.4 6.8 – 7.2 7.1 – 7.7 <.0001
A Dunnett adaption has been conducted on p-values for the error of first type including lower and upper limits of confidence intervall.Page 10 of 13
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unlikely to be sensitive to change and therefore not useful
for prospective measurement of aR in patients undergoing
treatment. We are currently undertaking a validation
study for the development of a state questionnaire for the
assessment of aR.
There is evidence that actimetrically measured rest-activity
rhythms are correlated with outcomes in metastatic color-
ectal cancer [10]. This supports a longstanding concept
that circadian rhythms and coordination of autonomic
functions are relevant to health status and in people with
chronic medical conditions, is associated with prognosis
[62]. Autonomic imbalance or loss of aR can be seen not
only as an early sign, but also as a underlying reaction to
various somatic diseases [63] and could be associated
with a loss of cardio-respiratory coordination. Therefore
there is a compelling reason to measure autonomic func-
tion and symptomatology and to assess rest/activity
rhythms and coordination with a psychometric clinical
instrument especially in multimodal CAM concepts. The
aR-scale has the potential to measure constitutional pat-
tern at the three different functional levels, which could
be important for detecting the response to multimodal
anthroposophical and CAM treatment. In our own prac-
tice we have applied it clinically. For example we use it to
screen for potential reduced heart rate variability (HRV) in
patients with diabetes, in whom low aR is associated with
reduced HRV [17]. We have also used the aR inventory as
a screen for sleep disorders: sleep apnoea, RLS and RLS-
treatment with Zincum valerianicum [64,65]. In breast
cancer in addition to its use as a screening instrument for
sleep disorders and cancer related fatigue [66] we employ
it for a constitutional assessment in patients receiving mis-
tletoe therapy [67].
Further studies of the clinical application of the aR inven-
tory are required before its potential role in clinical prac-
tice is realised.
Conclusion
Our evaluation of a long version of the aR inventory
found satisfactory to good reliability and convergent
validity and reasonable discriminant validity of the sub-
scales between different chronic conditions and healthy
volunteers. The physiological and clinical relevance of aR
needs to be evaluated in future studies, including investi-
gation of loss of autonomic functioning in different con-
ditions and its potential role as a measure of prognosis in
chronic conditions. Further studies will indicate if the aR
inventory has the potential to detect the subtle effects of
conventional and complementary therapies on a range of
symptoms experienced by patients that are not captured
by current measures.
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